In the framework of the Sino European Health Networking Hub (SENET), discover the first conceptual proposal workshop on the theme of advanced therapies, which will take place on 19 October. Dr. Nihal Engin Vrana will be speaking on the topic … Read More
NEWS
Newcomers in the team
Newcomers in the team SPARTHA Medical The #TeamSpartha is growing! In order to pursue SPARTHA Medical’s vision to grow and be a key player in the healthcare industry, we are pleased to announce the arrival of new employees who proudly … Read More
Research and development approval (CIR)
SPARTHA Medical has been granted for CIR accreditation SPARTHA Medical is pleased to announce the company has been granted for CIR accreditation for research and development (R&D) after scientific and technical expertise. • What does it mean ? The Research Tax Credit … Read More
Development of coatings using artificial intelligence: a world premiere.
Development of coatings using artificial intelligence: a world premiere. A collaboration between SPARTHA Medical, Preste and INSERM has resulted in publication of a pioneering paper in their areas of expertise in the journal Scientific Reports. Data from the scientific literature … Read More
US patent publication
Strasbourg, 10 June 2021. SPARTHA Medical, French MedTech company specializing in the development of multifonctional antimicrobial, antiviral and anti-inflammatory coatings, is pleased to announce the registration of its patent in the formulation of polymer-based coatings in the United States (US10864296B2). … Read More
Interview Business Inside | Forbes France
Issues and innovations around antibacterial coatings. SPARTHA Medical co-founders, Nihal Engin Vrana (Chief Executive Officer) and Philippe Lavalle (Chief Scientific Officer) have been interviewed by Jean Marc Sylvestre for the business TV show ”Business Inside”, in partnership with Forbes France. … Read More
43 TOP scoring 2020 InvestHorizon Accelerator companies
InvestHorizon is a programme financed by the European Commission, in association with Eureka, to facilitate series A funding for selected deep tech companies boosting their investment readiness and investor relations. The programme is run by a consortium coordinated by Tech … Read More
Selected among the 100 startups to invest in by Challenges
‘100 startups to invest in’ selection Released each year by the magazine Challenges, the 2021 edition of the ‘100 startups to invest in’ selection has included SPARTHA Medical. The top 100 SPARTHA’s presentation ”Our selection in this ranking marks a … Read More
SPARTHA Medical in the french news – March & April 2020
APRIL 2021 SPARTHA Medical presented its development and innovation objectives in this interview, published in the national news website actu.fr. SPARTHA Medical was featured in the local magazine Or Norme for the creation of a regional start-up incubation network called … Read More
The first organ-on-chip network in France
SPARTHA MEDICAL IS PART OF THE FIRST ORGAN-ON-CHIP INDUSTRY IN FRANCE. Structured by the BioValley France network in order to support and accelerate the emergence of innovative technologies, the network brings together major pharmaceutical and dermo-cosmetic industrial groups as well as research … Read More
SPARTHA Medical finished Innouvo Program
We are very pleased to have participated in this partnership adventure between the cities of Strasbourg and Boston, which will enable us to develop our activities for the American market. This program is in addition to the two other programs … Read More
SPARTHA Medical FUNDRAISING
Spartha Medical launched a Fundraising Campain in October 2020 … Read More
Collaboration with Dianosic
For next generation active intranasal asymmetric balloons with antibacterial and pro-healing properties … Read More
Participation in the 5th Healthcare & Life Science & Entrepreneurship Workshop
SPARTHA Medical’s participation in the 5th « Healthcare & Life Science & Entrepreneurship Workshop » SPARTHA Medical participated on September 3rd and 4th at the 5th « Healthcare & Life Science & Entrepreneurship Workshop » in the University of Pisa in Italy. The main … Read More
At war against microbes and viruses
SPARTHA Medical: At war against microbes and viruses Here is a new article on SPARTHA Medical in Point éco Alsace by the CCI. This article traces the evolution of the company’s activities. The start-up is developing antimicrobial coatings to fight infections … Read More
Bourse French Tech Emergence
Bourse French Tech Emergence We are happy to announce that we have been given Bourse French Tech Emergence by Bpifrance for our work on the development of biocompatible antiviral sprays. We would like to thank all our partners particularly SEMIA … Read More
Anti-SARS-CoV-2 coating project to protect hospital teams
Anti-SARS-CoV-2 coating project to protect hospital teams Explanation of our new anti SARS-CoV-2 project by our CSO. SPARTHA Medical is working on the development of antiviral coatings, applicable on the surface of medical devices, various surfaces and even eventually on … Read More
Polyarginine Decorated Polydopamine Nanoparticles With Antimicrobial Properties for Functionalization of Hydrogels
Polyarginine Decorated Polydopamine Nanoparticles With Antimicrobial Properties for Functionalization of Hydrogels A new research article from Spartha in collaboration with INSERM U1121 and University of Strasbourg. The article describes the delivery of our technology in nanoparticle format, which enables its … Read More
Hydrogels as Reservoirs for Antibiotic Substitutes
Polyanionic Hydrogels as Reservoirs for Polycationic Antibiotic Substitutes Providing Prolonged Antibacterial Activity A recent article on one of our hydrogel based formulations and their use in combination with woundcare products against multiple infections. In collaboration with INSERM UMR 1121. Implantation … Read More
Personalization of medical device interfaces
Personalization of medical device interfaces: decreasing implant-related complications by modular coatings and immunoprofiling A new editorial in Future Science Open Access Journal from our CEO and CSO. Personalized medicine currently plays a major role in reducing complications following surgery involving … Read More